Effects of the adjuvant cholera toxin on dendritic cells: stimulatory and inhibitory signals that result in the amplification of immune responses

Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588

Braun, 1999, Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor b1 and b2 chain expression, J. Exp. Med., 189, 541, 10.1084/jem.189.3.541

Chisari, 1974, Pathophysiologic effects of lethal and immunoregulatory doses of cholera enterotoxin in the mouse, J. Immunol., 113, 740, 10.4049/jimmunol.113.3.740

Cong, 1997, The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression, J. Immmunol., 159, 5301, 10.4049/jimmunol.159.11.5301

Cong, 2001, Effects of cholera toxin on macrophage production of co-stimulatory cytokines, Eur. J. Immunol., 31, 64, 10.1002/1521-4141(200101)31:1<64::AID-IMMU64>3.0.CO;2-P

Cox, 1997, Adjuvants, a classification and review of their modes of action, Vaccine, 15, 248, 10.1016/S0264-410X(96)00183-1

Elson, 1994, Mucosal adjuvants, 391

Gagliardi, 2000, Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming, Eur. J. Immunol., 30, 2394, 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y

Iwasaki, 1999, Mucosal immunity and inflammation, I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am. J. Physiol., 276, 1074

Lycke, 1997, The mechanism of cholera toxin adjuvanticity, Res. Immunol., 148, 504, 10.1016/S0923-2494(98)80144-2

Marinaro, 1999, Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens, Infect. Immun., 67, 1287, 10.1128/IAI.67.3.1287-1291.1999

Moser, 2000, Dendritic cell regulation of Th1-Th2 development, Nature Immunol., 1, 199, 10.1038/79734

Rappuoli, 1999, A relationship between the structure and function of cholera and Escherichia coli heat-labile enterotoxins and their immunological activity at mucosal surfaces, Immunol. Today, 20, 493, 10.1016/S0167-5699(99)01523-6

Sallusto, 2000, Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression, Immunol. Rev., 177, 134, 10.1034/j.1600-065X.2000.17717.x

Spangler, 1992, Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin, Microbiol. Rev., 56, 622, 10.1128/MMBR.56.4.622-647.1992

Staats, 1994, Mucosal immunity to infection with implications for vaccine development, Curr. Opin. Immunol., 6, 572, 10.1016/0952-7915(94)90144-9

Steinman, 1991, The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol., 9, 271, 10.1146/annurev.iy.09.040191.001415

Thomas, 1995, New mucosal adjuvants for Helicobacter pylori vaccines, Clin. Immunol. Immunopathol., 76, S94

Vines, 2000, Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route, Vaccine, 19, 655, 10.1016/S0264-410X(00)00254-1

Xu-Amano, 1993, Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa-associated tissues, J. Exp. Med., 178, 1309, 10.1084/jem.178.4.1309

Yamamoto, 1999, Direct effects on antigen presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant, J. Immunol., 162, 7015, 10.4049/jimmunol.162.12.7015